Hypotension induced by injection of intravenous ephedrine, of muscular ephedrine and of intradermal ephedrine. Hypotension due to drugs
Conditions
Interventions
Intervention 1: In The third group received an intravenous drug, Immediately after the entry of women into the operating room 10 milliliters per kilogram of body weight Ringer will be administered thr
Treatment - Drugs
Placebo
In The third group received an intravenous drug, Immediately after the entry of women into the operating room 10 milliliters per kilogram of body weight Ringer will be administered through IV No. 18 f
In The fourth group received a placebo, Immediately after the entry of women into the operating room 10 milliliters per kilogram of body weight Ringer will be administered through IV No. 18 for them.
In the second group received intradermal drug, Immediately after the entry of women into the operating room 10 milliliters per kilogram of body weight Ringer will be administered through IV No. 18 for
The first group received the drug muscle, Immediately after the entry of women into the operating room 10 milliliters per kilogram of body weight Ringer will be administered through IV No. 18 for them
Sponsors
Vice chancellor for research, Jahrom University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 20 to 30years old mothers who participate in class 1 and 2 ASA; tend to have spinal anesthesia; do not have a base systolic blood pressure more than 130 mmHg and less than 90 mmHg; do not have a history of high blood pressure and are consciously willing to participate in the project. Exclusion criteria: participants in class 3 and 4 ASA; patients with cardiovascular disease; people with tachycardia (over 100 beats per minute) and with bradycardia (less than 60 beats per minute); any history of hypertension, diabetes mellitus; patients with thyroid disease, using beta-agonists and beta blockers; preterm delivery; using banned drugs during pregnancy; preeclampsia and pre-eclampsia and eclampsia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Every 2.5 minutes to 10 minutes and then until 45 minutes every 5 minutes. Method of measurement: mmHg. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: every 15 minutes. Method of measurement: Scale Alderet.;Shivering. Timepoint: Every 15 minutes. Method of measurement: Scale rossely & mahajan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Farkhondehfal
Jahrom University of Medical Sciences
Outcome results
None listed